Today’s Top Buy: Curaleaf

Here’s why Curaleaf Holdings (TSXV:CURA) remains my top cannabis pick for investors to consider right now.

| More on:
Cannabis stocks have fallen.

A new “green rush” is upon us. Or, at least, cannabis investors hope so.

The key driver of this rush to cannabis stocks remains legalization. This time, anticipation of U.S. legalization has set the stage for another bout of hysteria of late.

Indeed, I believe that much of the hype right now in the cannabis space is unwarranted. That said, there are a few key companies I’d target for those looking to take advantage of the growth potential in this nascent industry.

Here’s why Curaleaf Holdings (TSXV:CURA) is my top pick for such investors today.

State-specific legalization driving speculation of federal legalization in U.S.

Late last month, New York governor Andrew Cuomo signed the S.854A/A.1248A bill that legalizes licensing of dispensaries across the state. Following this move, NY is set to become the country’s second-largest legal cannabis market. Legislative leaders will focus on setting up the state’s Cannabis Control Board and Office of Cannabis Management, which will regulate licensing, home cultivation, etc.

That’s big news in its own right.

However, cannabis investors are taking this news and running with it.

The hope many investors have is that these state-specific moves to legalize cannabis will ultimately force Biden’s hand. Biden has actually been relatively cold on the idea of legalizing cannabis, as per his previous commentary on the subject. Accordingly, cannabis investors appear to be latching onto any ray of hope President Biden could warm up to the idea.

New York is about as blue a state as they come, so there could be some political pressure that’s building on this front. However, with a pandemic still out of control south of the border, bigger priorities are taking over right now, as they should.

That’s not to discount the potential (or likelihood) of cannabis becoming federally legal in the United States. I’m just uncertain of the timing at this point.

Legalization potential varies among cannabis producers

If and when cannabis becomes legal, investors should want to own the top dogs in this space.

That means companies that actually have a footprint in the U.S.

Most Canadian cannabis producers are precluded from selling THC products in the U.S. by law (various banking regulations and U.S. listing regulations make it so). Accordingly, investing in some of the biggest Canadian cannabis names isn’t likely to be a winning bet right now, in my view.

The entry fee to get into the U.S. market following legalization is rising. To acquire one’s way into the U.S. will be ultra-expensive. Doing so organically will take time. In either case, investors in Canadian cannabis companies are likely to lose out to huge U.S. cannabis producers like Curaleaf with a dominant vertically integrated business model from coast to coast in the U.S.

Indeed, Curaleaf’s business model is among the most attractive of its peers. Additionally, the company’s valuation is much cheaper than many Canadian cannabis companies right now.

In my view, it’s the winner for those looking to play this space right now.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chris MacDonald has no position in any of the stocks mentioned.

More on Cannabis Stocks

Pot stocks are a riskier investment
Cannabis Stocks

Is the Worst Over for Canopy Growth Stock?

Down 99% from all-time highs Canopy Growth stock has burnt investor wealth and remains a high-risk investment.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Steer Clear: This Stock Spells Trouble

A newly listed cannabis stock is outperforming in 2024 but investors should stay clear to avoid trouble and losses.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

2 Best Marijuana Stocks to Buy This Month

Marijuana stocks in the U.S. such as Green Thumb and Curaleaf can help you deliver outsized gains to investors in…

Read more »

A cannabis plant grows.
Cannabis Stocks

Can Aurora Cannabis Stock Recover in 2024?

Aurora Cannabis stock is down 99% from all-time highs but remains a high-risk bet, despite its cheap valuation.

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

The Best Cannabis Stock to Buy Right Now

This cannabis stock has jumped 30% in the last few months, with even more growth on the way – all…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Down 99% From All-Time Highs, Is Canopy Growth Stock a Good Buy Right Now?

Canopy Growth stock is a high-risk investment due to its negative profit margins and challenging liquidity position.

Read more »

Marijuana plant and cannabis oil bottles isolated
Stocks for Beginners

Aurora Cannabis’ Reverse Stock Split: Is the Stock a Buy Today?

Cannabis stock Aurora (TSX:ACB) is consolidating shares once again, but what does this mean for investors?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Where Will Cannabis Stocks Be in 10 Years?

Cannabis stocks could see a huge shift upwards should marijuana be rescheduled in the U.S., but you can still buy…

Read more »